Literature DB >> 14756467

The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells.

Ellen B Cook1, James L Stahl, Julie B Sedgwick, Neal P Barney, Frank M Graziano.   

Abstract

BACKGROUND: Allergen-mediated mast cell activation is a key feature of ocular allergic diseases. Evidence of eosinophil-derived mediators in tears and conjunctival biopsy specimens has been associated with chronic ocular allergic inflammation.
OBJECTIVE: To examine the role of conjunctival mast cell mediators in eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation.
METHODS: Conjunctival cells were obtained by enzymatic digestion of cadaveric conjunctival tissues. Eosinophils were obtained from peripheral blood samples using negative magnetic bead selection. The effect of IgE-activated mast cell supernates on eosinophil degranulation and adherence to epithelial cells was compared with supernates obtained from mast cells pretreated with a degranulation inhibitor (olopatadine). Eosinophil adhesion was measured by eosinophil peroxidase assay, and eosinophil degranulation was measured by eosinophil-derived neurotoxin radioimmunoassay.
RESULTS: IgE-activated conjunctival mast cell supernates stimulated adhesion of eosinophils to epithelial cells (20.4% +/- 6.3% vs 3.1% +/- 1.0%; P = .048). Degranulation was not required for this process (no effect of olopatadine). IgE-activated mast cell supernates stimulated eosinophil-derived neurotoxin release (108.89 +/- 8.27 ng/10(6) cells vs 79.45 +/- 5.21 ng/10(6) cells for controls, P = .02), which was significantly inhibited by pretreatment of mast cells with a degranulation inhibitor (79.22 +/- 4.33 ng/10(6) cells vs 61.09 +/- 5.39 ng/10(6) cells for olopatadine pretreated and untreated, respectively, P = .02).
CONCLUSIONS: Mediators released from conjunctival mast cells promote eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation. Degranulation inhibition studies suggest that different mast cell mediators are involved in regulation of these events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14756467     DOI: 10.1016/S1081-1206(10)61712-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  3 in total

1.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

2.  An open microfluidic coculture model of fibroblasts and eosinophils to investigate mechanisms of airway inflammation.

Authors:  Yuting Zeng; Xiaojing Su; Meg G Takezawa; Paul S Fichtinger; Ulri N Lee; Jeffery W Pippin; Stuart J Shankland; Fang Yun Lim; Loren C Denlinger; Nizar N Jarjour; Sameer K Mathur; Nathan Sandbo; Erwin Berthier; Stephane Esnault; Ksenija Bernau; Ashleigh B Theberge
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29

3.  IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation.

Authors:  Ellen B Cook; James L Stahl; Elizabeth A Schwantes; Kristen E Fox; Sameer K Mathur
Journal:  Clin Mol Allergy       Date:  2012-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.